Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Rapid pneumococcal evolution in response to clinical interventions.

Croucher NJ, Harris SR, Fraser C, Quail MA, Burton J, van der Linden M, McGee L, von Gottberg A, Song JH, Ko KS, Pichon B, Baker S, Parry CM, Lambertsen LM, Shahinas D, Pillai DR, Mitchell TJ, Dougan G, Tomasz A, Klugman KP, Parkhill J, Hanage WP, Bentley SD.

Science. 2011 Jan 28;331(6016):430-4. doi: 10.1126/science.1198545.

2.

Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.

Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, Kellenberg J, Huang SS, Goldstein R, Hanage WP.

Pediatr Infect Dis J. 2007 Jun;26(6):468-72.

PMID:
17529860
3.

The changing epidemiology of Streptococcus pneumoniae serotype 19A clonal complexes.

Tyrrell GJ.

J Infect Dis. 2011 May 15;203(10):1345-7. doi: 10.1093/infdis/jir056. Epub 2011 Mar 11. No abstract available.

4.

Genetic characterisation of Malawian pneumococci prior to the roll-out of the PCV13 vaccine using a high-throughput whole genome sequencing approach.

Everett DB, Cornick J, Denis B, Chewapreecha C, Croucher N, Harris S, Parkhill J, Gordon S, Carrol ED, French N, Heyderman RS, Bentley SD.

PLoS One. 2012;7(9):e44250. doi: 10.1371/journal.pone.0044250. Epub 2012 Sep 10.

5.

Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain.

Ardanuy C, Rolo D, Fenoll A, Tarrago D, Calatayud L, Liñares J.

J Antimicrob Chemother. 2009 Sep;64(3):507-10. doi: 10.1093/jac/dkp210. Epub 2009 Jun 17.

PMID:
19535383
6.

Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape.

Croucher NJ, Chewapreecha C, Hanage WP, Harris SR, McGee L, van der Linden M, Song JH, Ko KS, de Lencastre H, Turner C, Yang F, Sá-Leão R, Beall B, Klugman KP, Parkhill J, Turner P, Bentley SD.

Genome Biol Evol. 2014 Jun 10;6(7):1589-602. doi: 10.1093/gbe/evu120.

7.

Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.

Techasaensiri C, Messina AF, Katz K, Ahmad N, Huang R, McCracken GH Jr.

Pediatr Infect Dis J. 2010 Apr;29(4):294-300. doi: 10.1097/INF.0b013e3181c2a229.

PMID:
19949357
8.

Molecular characteristics of erythromycin-resistant Streptococcus pneumoniae from pediatric patients younger than five years in Beijing, 2010.

Zhou L, Ma X, Gao W, Yao KH, Shen AD, Yu SJ, Yang YH.

BMC Microbiol. 2012 Oct 9;12:228. doi: 10.1186/1471-2180-12-228.

9.

Clonal expansion within pneumococcal serotype 6C after use of seven-valent vaccine.

Loman NJ, Gladstone RA, Constantinidou C, Tocheva AS, Jefferies JM, Faust SN, O'Connor L, Chan J, Pallen MJ, Clarke SC.

PLoS One. 2013 May 28;8(5):e64731. doi: 10.1371/journal.pone.0064731. Print 2013.

10.

The antimicrobial resistance profile of Streptococcus pneumoniae.

Reinert RR.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:7-11. doi: 10.1111/j.1469-0691.2009.02724.x. Review.

12.

Role of conjugative elements in the evolution of the multidrug-resistant pandemic clone Streptococcus pneumoniaeSpain23F ST81.

Croucher NJ, Walker D, Romero P, Lennard N, Paterson GK, Bason NC, Mitchell AM, Quail MA, Andrew PW, Parkhill J, Bentley SD, Mitchell TJ.

J Bacteriol. 2009 Mar;191(5):1480-9. doi: 10.1128/JB.01343-08. Epub 2008 Dec 29.

13.

Increase of pneumococcal serotype 19A in Italy is due to expansion of the piliated clone ST416/CC199.

Del Grosso M, Camilli R, D'Ambrosio F, Petrucci G, Melchiorre S, Moschioni M, Gherardi G, Pantosti A.

J Med Microbiol. 2013 Aug;62(Pt 8):1220-5. doi: 10.1099/jmm.0.061242-0. Epub 2013 May 30.

PMID:
23722433
14.

Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.

Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH Jr.

Pediatr Infect Dis J. 2007 Jun;26(6):461-7.

PMID:
17529859
15.

Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.

Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B.

J Infect Dis. 2008 Apr 1;197(7):1016-27. doi: 10.1086/528996.

PMID:
18419539
16.

Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.

Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B; Active Bacterial Core Surveillance Team..

J Infect Dis. 2005 Dec 1;192(11):1988-95. Epub 2005 Nov 1.

PMID:
16267772
17.

Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.

Picazo JJ.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:4-6. doi: 10.1111/j.1469-0691.2009.02723.x. Review.

18.

Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children.

van der Linden M, Reinert RR, Kern WV, Imöhl M.

BMC Infect Dis. 2013 Feb 5;13:70. doi: 10.1186/1471-2334-13-70.

19.

Genomics. The genomic view of bacterial diversification.

Enright MC, Spratt BG.

Science. 2011 Jan 28;331(6016):407-9. doi: 10.1126/science.1201690. No abstract available.

PMID:
21273474
20.

Shifting genetic structure of invasive serotype 19A pneumococci in the United States.

Beall BW, Gertz RE, Hulkower RL, Whitney CG, Moore MR, Brueggemann AB.

J Infect Dis. 2011 May 15;203(10):1360-8. doi: 10.1093/infdis/jir052. Epub 2011 Mar 11.

Supplemental Content

Support Center